Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults
Pek Kei Im(University of Oxford), Xiaoming Yang(Nanjing Forestry University), Dianjianyi Sun(Peking University), Canqing Yu(Peking University), Christiana Kartsonaki(University of Oxford), Maria Kakkoura(University of Oxford), Iona Y. Millwood(University of Oxford), Jun Lv(Shanghai Jiao Tong University), Olaa Mohamed-Ahmed(UK Health Security Agency), Huaidong Du(University of Oxford), Liming Li(Peking University), Zhengming Chen(Cornell University), Yiping Chen(University of Oxford), Ling Yang(Tongji University), Hua Zhang(University of Oxford)
Cited by 9
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919
Vitamin C selectively kills <i>KRAS</i> and <i>BRAF</i> mutant colorectal cancer cells by targeting GAPDH
|Science|2015|907
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18
|The Lancet|2021|579
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
|Cell Genomics|2022|408